NCT00629473 2017-11-22Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced MalignanciesCelgenePhase 1 Completed86 enrolled
NCT00667082 2017-11-22NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or LymphomaCelgenePhase 1 Completed22 enrolled